Pfizer (NYSE:PFE) Stock Analyst Ratings

By / / Pfizer

Pfizer (NYSE:PFE) Stock Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/31/2024 64.11% Cantor Fitzgerald → $45 Reiterates Overweight → Overweight
01/09/2024 64.11% Cantor Fitzgerald → $45 Reiterates Overweight → Overweight
01/04/2024 16.7% TD Cowen → $32 Downgrades Outperform → Market Perform
12/14/2023 31.29% Truist Securities $42 → $36 Maintains Buy
12/14/2023 -1.53% UBS $34 → $27 Maintains Neutral
12/14/2023 2.12% Barclays $34 → $28 Maintains Equal-Weight
12/04/2023 53.17% Truist Securities → $42 Reiterates Buy → Buy
11/20/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
11/01/2023 24% Barclays $35 → $34 Maintains Equal-Weight
11/01/2023 34.94% Morgan Stanley $39 → $37 Maintains Equal-Weight
10/20/2023 24% UBS $36 → $34 Assumes Neutral → Neutral
10/17/2023 53.17% Truist Securities $62 → $42 Maintains Buy
10/17/2023 42.23% Morgan Stanley $40 → $39 Maintains Equal-Weight
10/17/2023 27.64% Wells Fargo $39 → $35 Maintains Equal-Weight
10/16/2023 20.35% BMO Capital $44 → $33 Maintains Outperform
10/16/2023 27.64% Citigroup $42 → $35 Maintains Neutral
10/16/2023 24% JP Morgan $36 → $34 Maintains Neutral
10/16/2023 27.64% Wells Fargo $39 → $35 Maintains Equal-Weight
10/16/2023 42.23% Jefferies $38 → $39 Upgrades Hold → Buy
10/06/2023 31.29% JP Morgan $39 → $36 Maintains Neutral
10/02/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
09/18/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
09/13/2023 126.11% Truist Securities → $62 Reiterates Buy → Buy
09/05/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
08/30/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
08/22/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
08/02/2023 126.11% Truist Securities $64 → $62 Maintains Buy
08/02/2023 45.88% Morgan Stanley $42 → $40 Maintains Equal-Weight
08/02/2023 60.47% BMO Capital $45 → $44 Maintains Outperform
07/21/2023 53.17% Morgan Stanley $43 → $42 Maintains Equal-Weight
07/14/2023 82.35% HSBC → $50 Initiates Coverage On → Buy
07/11/2023 56.82% Morgan Stanley $43 → $43 Reiterates Equal-Weight → Equal-Weight
07/11/2023 38.58% Barclays $40 → $38 Maintains Equal-Weight
06/29/2023 45.88% Credit Suisse $47 → $40 Downgrades Outperform → Neutral
06/23/2023 173.52% Cantor Fitzgerald $75 → $75 Reiterates Overweight → Overweight
06/22/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
05/17/2023 173.52% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
05/11/2023 38.58% Daiwa Capital → $38 Downgrades Outperform → Neutral
05/03/2023 71.41% Credit Suisse $50 → $47 Maintains Outperform
05/03/2023 45.88% Barclays $43 → $40 Maintains Equal-Weight
04/21/2023 64.11% B of A Securities $50 → $45 Maintains Neutral
04/12/2023 56.82% Barclays $44 → $43 Maintains Equal-Weight
04/10/2023 60.47% Morgan Stanley $45 → $44 Maintains Equal-Weight
03/17/2023 60.47% Wells Fargo $50 → $44 Maintains Equal-Weight
03/06/2023 56.82% Jefferies → $43 Initiates Coverage On → Hold
02/07/2023 86% Daiwa Capital → $51 Upgrades Neutral → Outperform
02/01/2023 64.11% Morgan Stanley $53 → $45 Maintains Equal-Weight
02/01/2023 173.52% Cantor Fitzgerald → $75 Reiterates → Overweight
02/01/2023 82.35% Credit Suisse $54 → $50 Maintains Outperform
02/01/2023 93.29% BMO Capital $55 → $53 Maintains Outperform
02/01/2023 60.47% Barclays $49 → $44 Maintains Equal-Weight
02/01/2023 67.76% Atlantic Equities $50 → $46 Maintains Neutral
02/01/2023 75.05% SVB Leerink $49 → $48 Maintains Market Perform
01/26/2023 71.41% UBS $55 → $47 Downgrades Buy → Neutral
01/17/2023 82.35% Wells Fargo $54 → $50 Downgrades Overweight → Equal-Weight
01/04/2023 118.82% B of A Securities → $60 Downgrades Buy → Neutral
12/14/2022 93.29% Morgan Stanley $51 → $53 Maintains Equal-Weight
12/13/2022 118.82% Goldman Sachs $47 → $60 Upgrades Neutral → Buy
11/18/2022 100.58% Credit Suisse → $55 Initiates Coverage On → Outperform
11/03/2022 78.7% SVB Leerink $48 → $49 Maintains Market Perform
11/02/2022 96.94% Wells Fargo $55 → $54 Maintains Overweight
11/02/2022 78.7% Barclays $44 → $49 Maintains Equal-Weight
11/02/2022 86% Morgan Stanley $50 → $51 Maintains Equal-Weight
10/12/2022 82.35% Morgan Stanley $49 → $50 Maintains Equal-Weight
10/12/2022 60.47% Barclays $50 → $44 Maintains Equal-Weight
10/11/2022 75.05% SVB Leerink $53 → $48 Maintains Market Perform
08/01/2022 89.64% Barclays $50 → $52 Maintains Equal-Weight
07/29/2022 93.29% SVB Leerink $55 → $53 Maintains Market Perform
07/08/2022 78.7% Morgan Stanley $52 → $49 Maintains Equal-Weight
05/04/2022 89.64% Morgan Stanley $55 → $52 Maintains Equal-Weight
05/04/2022 100.58% Wells Fargo $60 → $55 Maintains Overweight
04/05/2022 107.88% Citigroup $46 → $57 Maintains Neutral
02/10/2022 100.58% Morgan Stanley $60 → $55 Maintains Equal-Weight
01/07/2022 137.05% Wells Fargo $60 → $65 Maintains Overweight
01/05/2022 155.29% B of A Securities $59 → $70 Upgrades Neutral → Buy
12/17/2021 86% Goldman Sachs → $51 Initiates Coverage On → Neutral
12/15/2021 104.23% SVB Leerink $52 → $56 Maintains Market Perform
12/14/2021 104.23% Mizuho $44 → $56 Maintains Neutral
12/13/2021 118.82% UBS $52 → $60 Upgrades Neutral → Buy
12/10/2021 96.94% Barclays $44 → $54 Maintains Equal-Weight
12/09/2021 118.82% Wells Fargo → $60 Initiates Coverage On → Overweight
11/29/2021 118.82% Morgan Stanley $50 → $60 Maintains Equal-Weight
11/19/2021 118.82% BMO Capital → $60 Initiates Coverage On → Outperform
11/03/2021 75.05% SVB Leerink $50 → $48 Maintains Market Perform
10/12/2021 75.05% Morgan Stanley $45 → $48 Maintains Equal-Weight
09/20/2021 82.35% SVB Leerink $49 → $50 Maintains Market Perform
07/30/2021 56.82% Mizuho $42 → $43 Maintains Neutral
07/29/2021 64.11% Morgan Stanley $42 → $45 Maintains Equal-Weight
07/29/2021 78.7% SVB Leerink $47 → $49 Maintains Market Perform
06/17/2021 60.47% RBC Capital $43 → $44 Maintains Sector Perform
05/10/2021 53.17% Morgan Stanley $38 → $42 Maintains Equal-Weight
05/06/2021 53.17% Mizuho → $42 Downgrades Buy → Neutral
05/05/2021 56.82% SVB Leerink $39 → $43 Maintains Market Perform
03/26/2021 42.23% SVB Leerink $40 → $39 Maintains Market Perform
02/04/2021 49.53% DZ Bank → $41 Upgrades Hold → Buy
02/03/2021 45.88% SVB Leerink $44 → $40 Maintains Market Perform
02/03/2021 53.17% Mizuho $44 → $42 Maintains Buy
01/29/2021 38.58% Morgan Stanley $40 → $38 Maintains Equal-Weight
12/16/2020 53.17% RBC Capital $43 → $42 Downgrades Outperform → Sector Perform
11/19/2020 45.88% Goldman Sachs → $40 Reinstates → Neutral
11/10/2020 53.17% Bernstein → $42 Initiates Coverage On → Market Perform
10/28/2020 56.82% SVB Leerink $42 → $43 Maintains Market Perform
10/23/2020 53.17% Truist Securities → $42 Initiates Coverage On → Buy
10/12/2020 42.23% Atlantic Equities $44 → $39 Downgrades Overweight → Neutral
09/29/2020 38.58% Berenberg → $38 Initiates Coverage On → Hold
07/30/2020 53.17% Morgan Stanley $36 → $42 Maintains Equal-Weight
07/29/2020 42.23% UBS $37 → $39 Maintains Neutral
07/29/2020 53.17% SVB Leerink $39 → $42 Maintains Market Perform
06/16/2020 45.88% SVB Leerink → $40 Initiates Coverage On → Market Perform
06/01/2020 31.29% JP Morgan $37 → $36 Maintains Neutral
04/29/2020 34.94% Barclays $36 → $37 Maintains Equal-Weight
04/02/2020 31.29% Morgan Stanley $43 → $36 Maintains Equal-Weight
03/27/2020 60.47% RBC Capital $46 → $44 Maintains Outperform
02/27/2020 31.29% Barclays → $36 Initiates Coverage On → Equal-Weight
02/06/2020 53.17% Mizuho → $42 Initiates Coverage On → Buy
01/07/2020 67.76% RBC Capital → $46 Initiates Coverage On → Outperform
10/17/2019 34.94% B of A Securities → $37 Reinstates → Neutral
08/28/2019 31.29% DZ Bank → $36 Upgrades Sell → Hold
08/27/2019 38.58% Morgan Stanley $40 → $38 Maintains Equal-Weight
07/30/2019 — B of A Securities Downgrades Buy → Neutral
07/30/2019 — Morgan Stanley Downgrades Overweight → Equal-Weight
06/04/2019 75.05% Morgan Stanley → $48 Reinstates → Overweight
04/01/2019 75.05% B of A Securities $45 → $48 Maintains Buy
Scroll to Top